Dr. Ihor Gussak

PHILADELPHIA, July 12 /PRNewswire-FirstCall/ -- Joseph Esposito, CEO of eResearchTechnology, Inc. (eRT), (Nasdaq: ERES - News), a leading provider of centralized electrocardiographic (ECG) collection and interpretation services, announced today that Ihor Gussak has been named Vice President of Global Medical Affairs.
...
With more than 20 years of cardiology experience, Dr. Gussak joins eRT from Aventis Pharmaceuticals, where he served as Associate Global Clinical Director, Cardiovascular Global Product Realization.Dr. Gussak has broad academic experience in the U.S. and Europe and gained his cardiac safety expertise at one core ECG laboratory and established a second core ECG laboratory.He has participated in management of many clinical trials and is credited with major contributions and publications in the field of cardiovascular medicine.

In addition to defining ECG analysis results for cardiac safety implications, Dr. Gussak will consult with eRT's major pharmaceutical clients on cardiac safety determination and use of eRT's services and products during the protocol design process.He will also be responsible for developing the ongoing strategy for eRT's cardiac safety services and supporting technology, which will be driven through his formation and management of eRT's medical advisory council.The council will be comprised of thought leaders from academia, government, and the industry at large.He was also recently appointed Associate Editor of the Journal of Electrocardiology.

...
"Clients will immediately benefit from Dr. Gussak's industry perspective, and he will prove critical to meeting the increased demands of a growing industry."

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis.The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development.The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand, and the company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client.

Dr. Ihor Gussak, a New Jersey cardiologist and vice president of Global Medical Affairs for eResearch Technology Inc., has worked with the lab since 1993 and considers the facility the best of its kind.

"By ethical and educational standards, it's tops, you will not find anything better," Gussak said.

Dr. Ihor Gussak, a New Jersey cardiologist and vice president of Global Medical Affairs for eResearch Technology Inc., has worked with the lab since 1993 and considers the facility the best of its kind.

"By ethical and educational standards, it's tops, you will not find anything better," Gussak said.